By bridging the strengths of both KinderPharm and Auxiliis, we complement our overall pediatric clinical trials' capabilities. This strategic partnership allows us to provide cost-effective solutions to our clients through expedited drug development processes and global sourcing of pediatric patients.
Pediatrics is now an integral part of drug development both in the US and EU. Although there has been significant progress in establishing the regulatory framework for the development of medicines for children in the US and EU, many clinical, scientific, technical and regulatory challenges still remain for pediatric product labelling.
KinderPharm and Auxiliis are the first dedicated and fully integrated pediatric drug-development companies. Our common mission is to be the expert pediatric co-development partners and the outsourced “Pediatric Center of Excellence” for our clients.
We have a single goal of “Bringing Better Medicines to Children”. We strive to apply the best available scientific, technical, clinical and quality practices to serve the needs of our patients and deliver value to our customers. We believe our integrated “one-stop” service model enables us to efficiently and cost-effectively advance pediatric products through all the required stages of pre-clinical and clinical development.
Our comprehensive portfolio of pediatric development capabilities, combined with the talents and experience of our people, provide us with a unique set of expertise, skill and insight to tackle the most challenging of development issues.
About KinderPharm, LLC
KinderPharm, LLC, based in Exton, PA, is an expert pediatric co-development partner, focusing exclusively on pediatric drug development. Our out-sourced “Pediatric Center of Excellence” model is a unique resource of pediatricians, pharmacometricians, regulatory, drug safety and formulation scientists that develop pediatric drugs through all stages of development. Our seasoned teams bring expertise and insight to help effectively navigate the complex pediatric regulatory environments in the US and Europe. We are dedicated to one single goal namely “Bringing better medicines to children”. To learn more information about KinderPharm, visit www.kinderpharm.com.
About Auxiliis
Auxiliis, based in Amsterdam, is a full-service contract research organization dedicated exclusively to pediatric clinical trials. With more than 50 pediatricians in-house and a Central East European network of up to 200 pediatricians, Auxiliis is affiliated with Svabhegy Children Hospital in Budapest and has direct access to approximately 20,000 patients on a yearly basis. The company has built an impressive performance track record in therapeutic areas such as: cardiology, oncology, pulmonology, neurology, psychiatry, immunology and vaccines. Auxiliis’ directors are also among the founders of the Medicine Research Network Hungary that links pediatricians and patients’ groups across the country to cover all aspects of pediatric trials. To learn more about Auxiliis, visit www.auxiliis-pharma.com.
For further information, please contact:
Martin Graham, PhD, Chief Executive Officer, (610) 458-1052
Janet Welsko, Chief Operating Officer, (610) 458-1052
Lynda Graham, MBA, Chief Financial Officer, (610) 458-1052
For media inquiries, please contact:
Kristin Liezenga, Business Development Executive, (610) 458-1502
Contact
KinderPharm LLC
610-458-1051
***@kinderpharm.com
Photos: (Click photo to enlarge)
Read Full Story - KinderPharm LLC Partners with Auxiliis to Provide Global Access for Pediatric Drug Development and Patients | More news from this source
Press release distribution by PRLog
